EDGAR Filing Documents for 0001415889-11-000610

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001415889-11-000610

Filing Date

2011-07-12

Accepted

2011-07-11 18:25:22

Documents

Period of Report

2011-05-16

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FLUOROPHARMA 8K-A	fluoropharma8kajuly112011.htm	8-K/A	658181
2	AGREEMENT AND PLAN OF MERGER, DATED AS OF MAY 16, 2011, BY AND AMONG FLUOROPHARM	exhibit2-1.htm	EX-2.1	368359
3	FLUOROPHARMA, INC. AUDITED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31,	ex99-1.htm	EX-99.1	834484
4	UNAUDITED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED MARCH 31, 2011 AND 201	ex99-2.htm	EX-99.2	839278
5	PRO FORMA UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBE	ex99-3.htm	EX-99.3	683582
	Complete submission text file	0001415889-11-000610.txt		3385616

Mailing Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116

Business Address 500 BOYLSTON STREET SUITE 1600 BOSTON MA 02116 (617) 482-2333 X122

FLUOROPHARMA MEDICAL, INC. (Filer) CIK: 0001402785 (see all company filings)